"ICON Eyecare's mission is to improve lives through better vision. An ophthalmology practice rooted in surgical and medical services, we place the needs of our patients first, investing in industry-leading technology to ensure patient safety, comfort, and high-quality results. Serving Colorado's Western Slope, our dedicated team of eyecare experts can address a variety of eye health concerns ranging from cataracts and refractive errors to dry eye, glaucoma, and retinal issues. With over 20 years of experience, ICON's board-certified eye doctors are committed to delivering the highest-quality eyecare in Colorado and have improved the lives of more than 250,000 through customized vision correction procedures."

During the past decade, Icon Eye Care conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Eye Care" #1 collaborator was "Alcon Research" with 1 trials as a collaborator and "Icon Eye Care" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Icon Eye Care" are "Corneal Edema After Cataract Surgery" (1 trials), "Glaucoma" (1 trials), "Ocular Inflammation and Pain" (1 trials) and "Refractive Assessment" (1 trials). Many other conditions were trialed in "Icon Eye Care" in a lesser frequency.

Most popular intervention types in "Icon Eye Care" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "APP13007, 0.05%" (1 trials), "Beacon Aqueous Microshunt" (1 trials), "Matching Vehicle Placebo for APP13007, 0.05%" (1 trials), "Placebo" (1 trials) and "Procedure: Vivity Toric IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icon Eye Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Icon Eye Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Icon Eye Care, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Icon Eye Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".